chr2:211375721:> Detail (hg38) (ERBB4)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr2:212,240,446-213,403,565 |
| hg38 | chr2:211,375,721-212,538,841 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
| Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| breast cancer | Trastuzumab | D |
Predictive
|
Supports
|
Resistance |
N/A
|
2 | 25153719 | Detail |
| breast cancer | Lapatinib | D |
Predictive
|
Supports
|
Resistance |
N/A
|
3 | 25590338 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| siRNA knockdown of HER4 or inhibition with neratinib enhanced trastuzumab response in breast cancer ... | CIViC Evidence | Detail |
| ERBB4 protein expression was identified in breast cancer cell lines with acquired lapatinib resistan... | CIViC Evidence | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg38
- Position
- chr2:211,375,721-212,538,841
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- EXPRESSION
- Transcript 1 (CIViC Variant)
- ENST00000342788.4
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/365
Genome browser